Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

[18] Biologic agents have been developed to target ... White blood cell counts and lymphocyte counts increased during therapy and returned to within the normal range by therapy completion.

Investigators aimed to highlight aspects that may predict the time to relapse among patients with psoriasis who discontinued use of biologic therapy.

Learn characteristics for nebulization: particle size, stability, viscosity, device interactions, efficacy. Explore key properties for optimizing biologic dry powder formulations: stabilize molecule, ...

Objective Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated enzyme, that has been implicated as a biomarker ...

Emerging biologic therapies provide targeted options for managing type 2 inflammation, showing promise in improving patient outcomes. Assessing disease severity, patient history, and response to ...

Patients with asthma who switched biologics multiple times were younger, more likely to identify as Black, and had more ...

“These data show how we are strengthening our IMPACT platform to serve as our product engine, creating a range of biologic therapies designed to address diseases more effectively by optimizing ...

It leverages AI and machine learning to automate workflows, enabling scientists to manage complex biological data with greater accuracy.